Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients
dc.contributor.author | Sharma, Pratima | |
dc.contributor.author | Parikh, Neehar D. | |
dc.contributor.author | Yu, Jessica | |
dc.contributor.author | Barman, Pranab | |
dc.contributor.author | Derstine, Brian A. | |
dc.contributor.author | Sonnenday, Christopher J. | |
dc.contributor.author | Wang, Stewart C. | |
dc.contributor.author | Su, Grace L. | |
dc.date.accessioned | 2016-09-17T23:55:05Z | |
dc.date.available | 2017-11-01T15:31:29Z | en |
dc.date.issued | 2016-08 | |
dc.identifier.citation | Sharma, Pratima; Parikh, Neehar D.; Yu, Jessica; Barman, Pranab; Derstine, Brian A.; Sonnenday, Christopher J.; Wang, Stewart C.; Su, Grace L. (2016). "Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients." Liver Transplantation 22(8): 1092-1098. | |
dc.identifier.issn | 1527-6465 | |
dc.identifier.issn | 1527-6473 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/133616 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/133616/1/lt24458_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/133616/2/lt24458.pdf | |
dc.identifier.doi | 10.1002/lt.24458 | |
dc.identifier.source | Liver Transplantation | |
dc.identifier.citedreference | Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG, et al. Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management. J Bone Joint Surg Am 2011; 93: 1057 ‐ 1063. | |
dc.identifier.citedreference | Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13: 1549 ‐ 1556. | |
dc.identifier.citedreference | Englesbe MJ, Lee JS, He K, Fan L, Schaubel DE, Sheetz KH, et al. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg 2012; 256: 255 ‐ 261. | |
dc.identifier.citedreference | Krishnamurthy V, Zhang P, Ethiraj S, Enchakalody B, Waljee AK, Wang L, et al. Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk for cirrhosis. Clin Gastroenterol Hepatol 2015; 13: 360 ‐ 368. | |
dc.identifier.citedreference | Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 2006; 6: 1957 ‐ 1962. | |
dc.identifier.citedreference | Aaij R, Abellan Beteta C, Adametz A, Adeva B, Adinolfi M, Adrover C, et al.; for LHCb Collaboration. First evidence for the decay B(s)(0)→mu+ mu. Phys Rev Lett 2013; 110: 021801. | |
dc.identifier.citedreference | Harbaugh CM, Terjimanian MN, Lee JS, Alawieh AZ, Kowalsky DB, Tishberg LM, et al. Abdominal aortic calcification and surgical outcomes in patients with no known cardiovascular risk factors. Ann Surg 2013; 257: 774 ‐ 781. | |
dc.identifier.citedreference | Huhdanpaa H, Douville C, Baum K, Krishnamurthy VN, Holcombe S, Enchakalody B, et al. Development of a quantitative method for the diagnosis of cirrhosis. Scand J Gastroenterol 2011; 46: 1468 ‐ 1477. | |
dc.identifier.citedreference | Zhang P, Peterson M, Su GL, Wang SC. Visceral adiposity is negatively associated with bone density and muscle attenuation. Am J Clin Nutr 2015; 101: 337 ‐ 343. | |
dc.identifier.citedreference | Samelson EJ, Christiansen BA, Demissie S, Broe KE, Louie‐Gao Q, Cupples LA, et al. QCT measures of bone strength at the thoracic and lumbar spine: the Framingham Study. J Bone Miner Res 2012; 27: 654 ‐ 663. | |
dc.identifier.citedreference | Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 2013; 158: 588 ‐ 595. | |
dc.identifier.citedreference | Lee S, Chung CK, Oh SH, Park SB. Correlation between bone mineral density measured by dual‐energy X‐Ray absorptiometry and Hounsfield Units measured by diagnostic CT in lumbar spine. J Korean Neurosurg Soc 2013; 54: 384 ‐ 389. | |
dc.identifier.citedreference | Dasarathy S. Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation. Dig Dis Sci 2013; 58: 3103 ‐ 3111. | |
dc.identifier.citedreference | Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, Soejima Y, et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl 2014; 20: 401 ‐ 407. | |
dc.identifier.citedreference | Bari K, Sharma P. Impact of body mass index on posttransplant outcomes reexamined. Liver Transpl 2015; 21: 1238 ‐ 1240. | |
dc.identifier.citedreference | Pereira FB, Leite AF, de Paula AP. Relationship between pre‐sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab 2015; 59: 59 ‐ 65. | |
dc.identifier.citedreference | Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 2015; 30: 1718 ‐ 1725. | |
dc.identifier.citedreference | Meza‐Junco J, Montano‐Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013; 47: 861 ‐ 870. | |
dc.identifier.citedreference | Ilich JZ, Inglis JE, Kelly OJ, McGee DL. Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women. Osteoporos Int 2015; 26: 2587 ‐ 2595. | |
dc.identifier.citedreference | Sharma P, Welch K, Hussain H, Pelletier SJ, Fontana RJ, Marrero J, Merion RM. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci 2012; 57: 806 ‐ 812. | |
dc.identifier.citedreference | Feng S, Goodrich NP, Bragg‐Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783 ‐ 790. | |
dc.identifier.citedreference | Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez‐Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10: 36 ‐ 41. | |
dc.identifier.citedreference | Organ Procurement and Transplantation Network. Allocation of livers and intestines. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN_Policies.pdf#nameddest=Policy_09. Accessed April 17, 2016. | |
dc.identifier.citedreference | Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693 ‐ 699. | |
dc.identifier.citedreference | Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM. Survival benefit‐based deceased‐donor liver allocation. Am J Transplant 2009; 9 ( pt 2 ): 970 ‐ 981. | |
dc.identifier.citedreference | Englesbe MJ. Quantifying the eyeball test: sarcopenia, analytic morphomics, and liver transplantation. Liver Transpl 2012; 18: 1136 ‐ 1137. | |
dc.identifier.citedreference | Hamaguchi Y, Kaido T, Okumura S, Fujimoto Y, Ogawa K, Mori A, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 2014; 20: 1413 ‐ 1419. | |
dc.identifier.citedreference | Kirk PS, Friedman JF, Cron DC, Terjimanian MN, Wang SC, Campbell DA, et al. One‐year postoperative resource utilization in sarcopenic patients. J Surg Res 2015; 199: 51 ‐ 55. | |
dc.identifier.citedreference | Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271 ‐ 278. | |
dc.identifier.citedreference | Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, Malani PN. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013; 19: 1396 ‐ 1402. | |
dc.identifier.citedreference | Lee CS, Cron DC, Terjimanian MN, Canvasser LD, Mazurek AA, Vonfoerster E, et al. Dorsal muscle group area and surgical outcomes in liver transplantation. Clin Transplant 2014; 28: 1092 ‐ 1098. | |
dc.identifier.citedreference | Valero V 3rd, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg 2015; 19: 272 ‐ 281. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.